April 2 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O:
TRINETX COLLABORATES WITH REGENERON TO ACCESS DE-IDENTIFIED ELECTRONIC HEALTH RECORDS OF 300 MILLION PATIENTS TO DRIVE RESEARCH AND PRODUCT DEVELOPMENT IN LIFE SCIENCES AND DIGITAL HEALTH SOLUTIONS
REGENERON PHARMACEUTICALS INC: AS PART OF COLLABORATION, REGENERON WILL INVEST UP TO $200 MILLION IN TRINETX